Yohann Wittrant

5.6k total citations · 1 hit paper
57 papers, 2.9k citations indexed

About

Yohann Wittrant is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Yohann Wittrant has authored 57 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Rheumatology. Recurrent topics in Yohann Wittrant's work include Bone Metabolism and Diseases (15 papers), Bone health and treatments (9 papers) and Bone Tissue Engineering Materials (9 papers). Yohann Wittrant is often cited by papers focused on Bone Metabolism and Diseases (15 papers), Bone health and treatments (9 papers) and Bone Tissue Engineering Materials (9 papers). Yohann Wittrant collaborates with scholars based in France, United States and Belgium. Yohann Wittrant's co-authors include Dominique Heymann, Françoise Rédiní, Véronique Coxam, Sandrine Théoleyre, Jérôme Guicheux, Fabien Wauquier, Laurent Léotoing, Yannick Fortun, Steeve Kwan Tat and Marie-Jeanne Davicco and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yohann Wittrant

56 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling

2004 518 citations Sandrine Théoleyre, Yohann Wittrant et al. Cytokine & Growth Factor Reviews profile →

Peers

Countries citing papers authored by Yohann Wittrant

Since Specialization

Citations

This map shows the geographic impact of Yohann Wittrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohann Wittrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohann Wittrant more than expected).

Fields of papers citing papers by Yohann Wittrant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohann Wittrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohann Wittrant. The network helps show where Yohann Wittrant may publish in the future.

Co-authorship network of co-authors of Yohann Wittrant

This figure shows the co-authorship network connecting the top 25 collaborators of Yohann Wittrant. A scholar is included among the top collaborators of Yohann Wittrant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yohann Wittrant. Yohann Wittrant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bioavailable human metabolites from TOTUM-448 (plant-based formulation) maintain liver cell functionality in a hyperlipidic context that drives MASLD onset 2025 ·Scientific Reports ·Fabien Wauquier, Vivien Chavanelle, (unknown), (unknown), Yolanda F. Otero, Stéphanie Krisa, Josep Valls, (unknown), Bruno Pereira, (unknown), Nicolas Macian, Gisèle Pickering, (unknown), Murielle Cazaubiel, (unknown), Sébastien Peltier, S. Blanquet, Pascal Sirvent, Yohann Wittrant	0
2	A Low-Gluten Diet Reduces the Abundance of Potentially Beneficial Bacteria in Healthy Adult Gut Microbiota 2025 ·Nutrients ·Eve Delmas, Rea Bingula, Christophe Del’Homme, Nathalie Meunier, A. Caillé, (unknown), Ruddy Richard, Mariana Couto, Yohann Wittrant, Annick Bernalier‐Donadille	1
3	Human Serum, Following Absorption of Fish Cartilage Hydrolysate, Promotes Dermal Fibroblast Healing through Anti-Inflammatory and Immunomodulatory Proteins 2024 ·Biomedicines ·(unknown), Aurélie Guého, Régis Lavigne, Fabien Wauquier, (unknown), (unknown), Emmanuelle Com, Yohann Wittrant, Charles Pineau	1
4	Reduced Production of Pro-Inflammatory and Pro-Catabolic Factors by Human Serum Metabolites Derived from a Patented Saffron Extract Intake 2024 ·Pharmaceutics ·Line Pourtau, Fabien Wauquier, (unknown), David Gaudout, (unknown), (unknown), Carole Vaysse, Tristan Richard, Arnaud Courtois, Stéphanie Krisa, (unknown), Nicolas Macian, Gisèle Pickering, Yohann Wittrant	4
5	Circulating Human Metabolites Resulting from TOTUM-070 Absorption (a Plant-Based, Polyphenol-Rich Ingredient) Improve Lipid Metabolism in Human Hepatocytes: Lessons from an Original Ex Vivo Clinical Trial 2023 ·Nutrients ·Fabien Wauquier, (unknown), Stéphanie Krisa, Josep Valls, Cédric Langhi, Yolanda F. Otero, Pascal Sirvent, Sébastien Peltier, (unknown), Murielle Cazaubiel, (unknown), (unknown), (unknown), Nicolas Macian, Gisèle Pickering, Yohann Wittrant	2
6	Oral supplementation with fish cartilage hydrolysate in an adult population suffering from knee pain and function discomfort: results from an innovative approach combining an exploratory clinical study and an ex vivo clinical investigation 2023 ·BMC Musculoskeletal Disorders ·(unknown), (unknown), Mélanie Uebelhoer, Fabien Wauquier, (unknown), Anne‐Françoise Donneau, (unknown), (unknown), (unknown), Mélanie Wagner, (unknown), (unknown), Yohann Wittrant	5
7	Circulating Human Serum Metabolites Derived from the Intake of a Saffron Extract (Safr’InsideTM) Protect Neurons from Oxidative Stress: Consideration for Depressive Disorders 2022 ·Nutrients ·Fabien Wauquier, (unknown), Line Pourtau, David Gaudout, (unknown), (unknown), (unknown), Julien Gabaston, Carole Vaysse, (unknown), (unknown), Lucile Capuron, Nathalie Castanon, David Vauzour, (unknown), Nicolas Macian, Gisèle Pickering, Yohann Wittrant	19
8	Benefits of Circulating Human Metabolites from Fish Cartilage Hydrolysate on Primary Human Dermal Fibroblasts, an Ex Vivo Clinical Investigation for Skin Health Applications 2022 ·Nutrients ·Fabien Wauquier, (unknown), (unknown), (unknown), (unknown), Nicolas Macian, Gisèle Pickering, Yohann Wittrant	10
9	Non-targeted and targeted analysis of collagen hydrolysates during the course of digestion and absorption 2019 ·Analytical and Bioanalytical Chemistry ·Anne J. Kleinnijenhuis, Frédérique L. van Holthoon, Annet Maathuis, Barbara Vanhoecke, Janne Prawitt, Fabien Wauquier, Yohann Wittrant	24
10	Pinoresinol of olive oil decreases vitamin D intestinal absorption 2016 ·Food Chemistry ·Aurélie Goncalves, Marielle Margier, Camille Tagliaferri, Patrice Lebecque, Stéphane Georgé, Yohann Wittrant, Véronique Coxam, Marie Josèphe Amiot, Emmanuelle Reboul	15
11	GPR40, a free fatty acid receptor, differentially impacts osteoblast behavior depending on differentiation stage and environment 2015 ·Molecular and Cellular Biochemistry ·Claire Philippe, Fabien Wauquier, Bernard Lyan, Véronique Coxam, Yohann Wittrant	9
12	Muscle and bone, two interconnected tissues 2015 ·Ageing Research Reviews ·Camille Tagliaferri, Yohann Wittrant, Marie-Jeanne Davicco, Stéphane Walrand, Véronique Coxam	276
13	Olive Oil and Vitamin D Synergistically Prevent Bone Loss in Mice 2014 ·PLoS ONE ·Camille Tagliaferri, Marie-Jeanne Davicco, Patrice Lebecque, Stéphane Georgé, Marie Josèphe Amiot, Sylvie Mercier, (unknown), Alain Huertas, Stéphane Walrand, Yohann Wittrant, Véronique Coxam	20
14	The Free Fatty Acid Receptor G Protein-coupled Receptor 40 (GPR40) Protects from Bone Loss through Inhibition of Osteoclast Differentiation* 2013 ·Journal of Biological Chemistry ·Fabien Wauquier, Claire Philippe, Laurent Léotoing, Sylvie Mercier, Marie-Jeanne Davicco, Patrice Lebecque, Jérôme Guicheux, Paul Pilet, Elisabeth Miot-Noirault, Vincent Poitout, Thierry Alquier, Véronique Coxam, Yohann Wittrant	76
15	Borage and fish oils lifelong supplementation decreases inflammation and improves bone health in a murine model of senile osteoporosis 2011 ·Bone ·Fabien Wauquier, Valentin Barquissau, Laurent Léotoing, Marie-Jeanne Davicco, Patrice Lebecque, Sylvie Mercier, Claire Philippe, Elisabeth Miot-Noirault, Jean‐Michel Chardigny, Béatrice Morio, Yohann Wittrant, Véronique Coxam	24
16	Nox4 NAD(P)H Oxidase Mediates Src-dependent Tyrosine Phosphorylation of PDK-1 in Response to Angiotensin II 2008 ·Journal of Biological Chemistry ·Karen Block, Assaad A. Eid, Kathy K. Griendling, (unknown), Yohann Wittrant, Yves Gorin	115
17	Targeted expression of csCSF-1 in op/op mice ameliorates tooth defects 2006 ·Archives of Oral Biology ·(unknown), Jelica Gluhak‐Heinrich, Katie Woodruff, Yohann Wittrant, (unknown), Martine P. Roudier, Mary MacDougall	13
18	The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling breakdown → 2004 ·Cytokine & Growth Factor Reviews ·Sandrine Théoleyre, Yohann Wittrant, Steeve Kwan Tat, Yannick Fortun, Françoise Rédiní, Dominique Heymann	518
19	Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor κB ligand and MAPK 2003 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Sandrine Théoleyre, Yohann Wittrant, Séverine Couillaud, Patricia Vusio, Martine Berreur, Colin R. Dunstan, Frédéric Blanchard, Françoise Rédiní, Dominique Heymann	41
20	Regulation of osteoclast protease expression by RANKL 2003 ·Biochemical and Biophysical Research Communications ·Yohann Wittrant, Sandrine Théoleyre, Séverine Couillaud, Colin R. Dunstan, Dominique Heymann, Françoise Rédiní	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact